Volume 34 Number 23 June 11-18, 2015
Antimicrobials/ Vaccines/ Interventions
Trends in use of genotypic resistance testing and frequency of major drug resistance among antiretroviral-naive persons in the HIV Outpatient Study, 1999-2011.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_tDi6j3k1p9CW3fwK58dJOPh4DhoUIQdEpD6QLKRpbGfeyOoCdYuNJ4Q3hIkmLykwG84cPR6CyxqinRxLL1zVRDPslVF8hxbk6iIx_2XaNoKxQ_Hl9wC8zI=s0-d)
Buchacz K et al. J. Antimicrob. Chemother. 2015 May 15. (CDC Author)
Buchacz K et al. J. Antimicrob. Chemother. 2015 May 15. (CDC Author)
A global health diagnostic for personalized medicine in resource-constrained world settings: A simple PCR-RFLP method for genotyping CYP2B6 g.15582C>T and science and policy relevance for optimal use of antiretroviral drug efavirenz ![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_tDi6j3k1p9CW3fwK58dJOPh4DhoUIQdEpD6QLKRpbGfeyOoCdYuNJ4Q3hIkmLykwG84cPR6CyxqinRxLL1zVRDPslVF8hxbk6iIx_2XaNoKxQ_Hl9wC8zI=s0-d)
Evans J, et al. OMICS, June 2015, 19(6): 332-338.
Evans J, et al. OMICS, June 2015, 19(6): 332-338.
Engineered phagemids for nonlytic, targeted antibacterial therapies.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_tDi6j3k1p9CW3fwK58dJOPh4DhoUIQdEpD6QLKRpbGfeyOoCdYuNJ4Q3hIkmLykwG84cPR6CyxqinRxLL1zVRDPslVF8hxbk6iIx_2XaNoKxQ_Hl9wC8zI=s0-d)
Krom RJ et al. Nano Lett. 2015 Jun 8.
Krom RJ et al. Nano Lett. 2015 Jun 8.
A broad protection provided by matrix protein 2 (M2) of avian influenza virus.![External Web Site Icon External Web Site Icon](https://lh3.googleusercontent.com/blogger_img_proxy/AEn0k_tDi6j3k1p9CW3fwK58dJOPh4DhoUIQdEpD6QLKRpbGfeyOoCdYuNJ4Q3hIkmLykwG84cPR6CyxqinRxLL1zVRDPslVF8hxbk6iIx_2XaNoKxQ_Hl9wC8zI=s0-d)
Meng Q et al. Vaccine 2015 May 30.
Meng Q et al. Vaccine 2015 May 30.
No hay comentarios:
Publicar un comentario